The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 5
- 3 new, 2 renewals
- Median first-year cost
- $932,148
- $4,444,959 in all
- Institutions
- 4
- 5 contact PIs
- Patents
- 2
- from 1 funded project
Awards by fiscal year
Fiscal years 2014 to 2026.
Most frequent institutions
- UNIVERSITY OF CALIFORNIA LOS ANGELES2
- JOHNS HOPKINS UNIVERSITY1
- MASSACHUSETTS GENERAL HOSPITAL1
- UNIVERSITY OF SOUTHERN CALIFORNIA1
Most frequent study sections
- Special Emphasis Panel (ZCA1 RPRB-H (A1))5
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2023 | Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma Biofluids2U01CA230691-06 | Agrawal, NishantBettegowda, ChetanPapadopoulos, Nickolas | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $987,109 | Study section ZCA1 |
| FY2023 | Multi-cancer early detection using cell-free DNA methylome analysis1U01CA285010-01 | Bresalier, Robert SLi, WenyuanZhou, Xianghong Jasmine | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | First-year cost $952,611 | Study section ZCA1 |
| FY2023 | EFIRM Liquid Biopsy Research Laboratory: Early Lung Cancer Assessment2U01CA233370-06 | Aberle, Denise R.Hsu, WilliamKrysan, KostyantynStrom, Charles MartinWei, FangWong, David T | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | First-year cost $932,148 | Study section ZCA1 |
| FY2023 | Expanding early cancer detection with high throughput OCEANA - Ovarian Cancer Exosome Analysis with Nanoplasmonic Array1U01CA284982-01 | Castro, Cesar MLee, Hakho | MASSACHUSETTS GENERAL HOSPITAL, MA | First-year cost $877,641 | Study section ZCA1 |
| FY2023 | Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma1U01CA285013-01 | Kuhn, Peter | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | First-year cost $695,450 | Study section ZCA1 |
Patents from its funded projects
2 patents name 1 of the 5 funded projects.
- US 12,553,082 (opens the patent at USPTO, a PDF, in a new tab)METHODS AND MATERIALS FOR ASSESSING NUCLEIC ACIDSGranted February 17, 2026 to The Johns Hopkins UniversityU01CA230691 · JOHNS HOPKINS UNIVERSITY, MD
- US 12,442,038 (opens the patent at USPTO, a PDF, in a new tab)METHODS AND MATERIALS FOR ASSESSING NUCLEIC ACIDSGranted October 14, 2025 to The Johns Hopkins UniversityU01CA230691 · JOHNS HOPKINS UNIVERSITY, MD
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-12-0.3.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.